<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Q418/FY18 Infection Prevention: Vascular Access Adjunct Products

Posted by Susan Paquette on 4/3/19 11:25 AM

FY18 showed solid gains in all segments, up +5.7% YoY, as antimicrobial devices take the lead.

Prevention of HAIs continues to drive measures and practices to reduce Central Line Associated Bloodstream Infections (CLABSIs) and create demand for products that can aid in addressing these issues. Progress is being made and updated new patient safety data continues to show a downward trend in the annual number of hospital-acquired conditions. According to new analysis from AJRQ, hospital-acquired conditions (HACs) dropped 13% from 2014 to 2017. However, the number of SSIs did not change over the 3 years while CLABSI’s reported an estimated -6% decline from 2014 to 2017 (preliminary data).
Read More

Topics: Wound Care-Infection Prevention, Q418 Market Recaps

Q318 Infection Prevention: Vascular Access Adjunct Products Market Recap

Posted by Susan Paquette on 1/4/19 9:30 AM

Growth continues for another quarter as market leaders gain more share.

For Q318, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market grew +4.3% YoY.

Among the many topics covered in the Q318 Infection Prevention Market Recap are:

Read More

Topics: Wound Care-Infection Prevention, Q318 Market Recaps

Q218 Infection Prevention Recap: Vascular Access Adjunct Products

Posted by Susan Paquette on 9/28/18 12:56 PM

Growth continues for all segments during the quarter, led by top 3 players.


For Q218, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market grew +4.3% YoY...

Among the many topics covered in detail in the comprehensive Q218 Infection Prevention Market Recap are:

Read More

Topics: Wound Care-Infection Prevention

SmartTRAK Publication Alert: Q118 Infection Prevention Market Results

Posted by Susan Paquette on 6/25/18 10:38 AM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Infection Prevention Market Recap.

For Q118, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market grew +3.9% YoY. Market gains continue as BD moves into leadership position...

Among the many topics covered in the full Q118 Infection Prevention Market Recap are: 

Read More

Topics: Wound Care-Infection Prevention

SmartTRAK's Final 2017 Infection Prevention Financial Results

Posted by Susan Paquette on 4/11/18 11:39 AM

The FY17 Vascular Access Adjunct Products market showed solid gains in all segments, up +4.7% YoY, and the closing of major acquisitions reshapes the competitive landscape ahead.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Spine Market Recap and Financial Dashboard.

Among the many topics covered in the Q417/FY17 US Infection Prevention Market Recap are:

Read More

Topics: Wound Care-Infection Prevention

SmartTRAK Publication Alert: Q317 Wound Care Infection Prevention Quarterly Market Recap

Posted by Susan Paquette on 12/19/17 2:49 PM

Q317 Infection Prevention: Vascular Access Adjunct Products 

A slowdown in growth for another quarter.

By Susan Paquette, VP Wound

For Q317, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market reached new market revenue heights in dollars and growth.

Read More

Topics: Wound Care-Infection Prevention

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts